Alyeska Investment Group, L.P. Sc Pharmaceuticals Inc. Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.17 - $9.41 $14,708 - $26,771	-2,845 Reduced 0.79%	355,690 $1.88 Million
Q3 2020 Nov 16, 2020	SELL	$7.12 - $8.86 $214,084 - $266,402	-30,068 Reduced 7.74%	358,535 $2.67 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $1.48 Million - $2.32 Million	211,468 Added 119.38%	388,603 $2.86 Million
Q4 2018 Feb 14, 2019	SELL	$3.76 - $5.61 $201,851 - $301,167	-53,684 Reduced 23.26%	177,135 $666,000
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $40,816 - $113,667	7,381 Added 3.3%	230,819 $1.31 Million
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $562,849 - $838,946	48,438 Added 27.68%	223,438 $2.77 Million
Q4 2017 Feb 14, 2018	BUY	$11.8 - $17.31 $2.07 Million - $3.03 Million	175,000	175,000 $2.12 Million

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $97M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.